Xiaojing Lu

429 total citations
20 papers, 241 citations indexed

About

Xiaojing Lu is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Gastroenterology. According to data from OpenAlex, Xiaojing Lu has authored 20 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Cancer Research and 4 papers in Gastroenterology. Recurrent topics in Xiaojing Lu's work include Sarcoma Diagnosis and Treatment (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (2 papers). Xiaojing Lu is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (2 papers). Xiaojing Lu collaborates with scholars based in China, United States and Taiwan. Xiaojing Lu's co-authors include Qi Cai, Ke Ding, Yuzhi Pang, Yuexiang Wang, Kehu Yang, Cuncun Lu, Yanying Shen, Hui Cao, Feifei Xie and Nan Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and The Journal of Experimental Medicine.

In The Last Decade

Xiaojing Lu

18 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojing Lu China 9 95 59 46 44 29 20 241
Elliot Kahen United States 7 174 1.8× 103 1.7× 45 1.0× 35 0.8× 13 0.4× 7 302
Ari Pelcovits United States 7 121 1.3× 31 0.5× 68 1.5× 36 0.8× 110 3.8× 23 264
Cecília Correia Portugal 12 124 1.3× 24 0.4× 32 0.7× 48 1.1× 92 3.2× 25 267
Igor Shendrik United States 6 123 1.3× 37 0.6× 60 1.3× 32 0.7× 12 0.4× 13 310
Yuya Aoto Japan 12 199 2.1× 39 0.7× 12 0.3× 13 0.3× 32 1.1× 29 324
Miho Ushijima Japan 10 92 1.0× 57 1.0× 32 0.7× 35 0.8× 6 0.2× 21 261
Baocheng Gong China 10 140 1.5× 95 1.6× 77 1.7× 72 1.6× 7 0.2× 30 310
Daria Domańska Poland 13 135 1.4× 63 1.1× 68 1.5× 43 1.0× 10 0.3× 18 328
Sandra von Hardenberg Germany 10 100 1.1× 43 0.7× 25 0.5× 32 0.7× 10 0.3× 25 245
Manmohan R. Leleti United States 7 71 0.7× 52 0.9× 42 0.9× 10 0.2× 15 0.5× 31 262

Countries citing papers authored by Xiaojing Lu

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Lu more than expected).

Fields of papers citing papers by Xiaojing Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Lu. The network helps show where Xiaojing Lu may publish in the future.

Co-authorship network of co-authors of Xiaojing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Lu. A scholar is included among the top collaborators of Xiaojing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Lu. Xiaojing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lin, Xu Chen, Xiaojing Lu, et al.. (2025). Gambogic Acid Based Coordination Polymer Reinforces High‐Intensity Focused Ultrasound Treatment of Gynecologic Malignancies. Advanced Materials. 37(26). e2501664–e2501664. 2 indexed citations
2.
Kerdsin, Anusak, Jianping Wang, Mingliu Wang, et al.. (2025). Streptococcus suis serotype 5: Emerging zoonotic threat with distinct genomic heterogeneity. Virulence. 16(1). 2523882–2523882. 1 indexed citations
3.
Lu, Xiaojing, Yanying Shen, Yuxiang Luo, et al.. (2025). Integrated screens identify AURKB dependency in advanced gastrointestinal stromal tumors. The Journal of Experimental Medicine. 222(11).
4.
5.
Liu, Kefeng, Zhirong Yang, Xiaojing Lu, et al.. (2023). The origin of vitamin B12 levels and risk of all-cause, cardiovascular and cancer specific mortality: A systematic review and dose-response meta-analysis. Archives of Gerontology and Geriatrics. 117. 105230–105230. 10 indexed citations
6.
Luo, Yuxiang, Xiaoxiao Liu, Xiaojing Lu, et al.. (2023). Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Journal for ImmunoTherapy of Cancer. 11(12). e007678–e007678. 8 indexed citations
7.
Lu, Xiaojing, Yuzhi Pang, Hui Cao, et al.. (2021). Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors. Cancer Research. 81(9). 2481–2494. 31 indexed citations
8.
Chen, Jiahui, Haibo Wang, Xiaojing Lu, Kehu Yang, & Cuncun Lu. (2021). Safety and efficacy of stem cell therapy: an overview protocol on published meta-analyses and evidence mapping. Annals of Translational Medicine. 9(3). 270–270. 8 indexed citations
9.
Lu, Xiaojing, Cuncun Lu, Yongjie Yang, et al.. (2021). Current Status and Trends in Peptide Receptor Radionuclide Therapy in the Past 20 Years (2000–2019): A Bibliometric Study. Frontiers in Pharmacology. 12. 624534–624534. 33 indexed citations
10.
Zhu, Li, Yuzhi Pang, Zhang Li, et al.. (2020). Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors. Gastric Cancer. 23(5). 837–847. 6 indexed citations
11.
Wang, Xiufang, et al.. (2020). A systematic review of the clinical and genetic characteristics of Chinese patients with cystic fibrosis. Pediatric Pulmonology. 55(11). 3005–3011. 12 indexed citations
12.
Li, Zhang, Chenghao Shao, Xiaoxiao Liu, et al.. (2019). Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression. Carcinogenesis. 41(1). 44–55. 18 indexed citations
13.
Pang, Yuzhi, Feifei Xie, Hui Cao, et al.. (2019). Mutational inactivation of mTORC1 repressor gene DEPDC5 in human gastrointestinal stromal tumors. Proceedings of the National Academy of Sciences. 116(45). 22746–22753. 27 indexed citations
14.
Jiang, Qian, Xiaojing Lu, Chao Gao, et al.. (2018). Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia. BioMed Research International. 2018. 1–10. 25 indexed citations
15.
Liu, Jieyu, et al.. (2018). Utility of GDF‐15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta‐analysis. FEBS Open Bio. 9(1). 35–42. 16 indexed citations
16.
Shi, Tong, Liqin Li, Xuejun Chen, et al.. (2017). Toll-like receptor 5 agonist CBLB502 induces radioprotective effects <italic>in vitro</italic>. Acta Biochimica et Biophysica Sinica. 49(6). 487–495. 7 indexed citations
17.
Wang, Chen, et al.. (2016). Microdialysis combined with liquid chromatography-tandem mass spectrometry for the determination of nimodipine in the guinea pig hippocampus. Journal of Chromatography B. 1017-1018. 226–232. 2 indexed citations
18.
Zhang, Wei, et al.. (2015). [Juglone inhibits proliferation and induces apoptosis of human cervical squamous cancer SiHa cells].. PubMed. 31(2). 186–9. 8 indexed citations
19.
Lu, Xiaojing, Qian Jiang, Gang Li, et al.. (2013). [Preliminary analysis of aberrant expression of plasma miR-223 in pediatric acute lymphoblastic leukemia with a direct RT-PCR assay].. PubMed. 21(1). 68–72. 1 indexed citations
20.
Lu, Xiaojing, Qi Cai, & Ke Ding. (2011). Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation. Current Medicinal Chemistry. 18(14). 2146–2157. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elliot Kahen Breakdown of academic impact, for papers by Ari Pelcovits Breakdown of academic impact, for papers by Cecília Correia Breakdown of academic impact, for papers by Igor Shendrik Breakdown of academic impact, for papers by Yuya Aoto Breakdown of academic impact, for papers by Miho Ushijima Breakdown of academic impact, for papers by Baocheng Gong Breakdown of academic impact, for papers by Daria Domańska Breakdown of academic impact, for papers by Sandra von Hardenberg Breakdown of academic impact, for papers by Manmohan R. Leleti
Rankless by CCL
2026